Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ockenga

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Der Internist|March 3, 2006
[Enteral nutrition]M Pirlich, H Lochs, J Ockenga
Gut|October 15, 1998
Steatorrhoea and pancreatic disease in HIV infected patientsJ Ockenga, M Göke, M P Manns
Gut|July 31, 2001
Evaluation of the role of CFTR in alcohol related pancreatic diseaseJ Ockenga, M Stuhrmann, M P Manns
Zeitschrift Fur Gastroenterologie|November 19, 2002
[Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions]J Ockenga, M Pirlich, S Gastell, et al.
Der Internist|November 21, 2000
[Artificial nutrition in intensive internal medicine. Chances and problems]S C Bischoff, J Ockenga, M P Manns
Alimentary Pharmacology & Therapeutics|April 25, 2006
Repeated administration of a vitamin preparation containing glycocholic acid in patients with hepatobiliary diseaseK Rifai, J Ockenga, M P Manns, et al.
AIDS (London, England)|December 2, 1998
Bound leptin is regulated by tumour necrosis factor-alpha in HIV-infected patients: a potential mediator of wasting?J Ockenga, A Widjaja, M Holtmannspötter, et al.
Annals of Nutrition & Metabolism|September 6, 2000
Tumor necrosis factor, interleukin-6,and epinephrine are associated with hypermetabolism in AIDS patients with acute opportunistic infectionsU Süttmann, M Holtmannspötter, J Ockenga, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 28, 2005
Nutritional assessment and management in hospitalised patients: implication for DRG-based reimbursement and health care qualityJ Ockenga, M Freudenreich, R Zakonsky, et al.
Gastroenterology|March 26, 1999
Octreotide for therapy of chylous ascites in yellow nail syndromeA Widjaja, K F Gratz, J Ockenga, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Der Internist|March 3, 2006
[Enteral nutrition]M Pirlich, H Lochs, J Ockenga
Gut|October 15, 1998
Steatorrhoea and pancreatic disease in HIV infected patientsJ Ockenga, M Göke, M P Manns
Gut|July 31, 2001
Evaluation of the role of CFTR in alcohol related pancreatic diseaseJ Ockenga, M Stuhrmann, M P Manns
Zeitschrift Fur Gastroenterologie|November 19, 2002
[Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions]J Ockenga, M Pirlich, S Gastell, et al.
Der Internist|November 21, 2000
[Artificial nutrition in intensive internal medicine. Chances and problems]S C Bischoff, J Ockenga, M P Manns
Alimentary Pharmacology & Therapeutics|April 25, 2006
Repeated administration of a vitamin preparation containing glycocholic acid in patients with hepatobiliary diseaseK Rifai, J Ockenga, M P Manns, et al.
AIDS (London, England)|December 2, 1998
Bound leptin is regulated by tumour necrosis factor-alpha in HIV-infected patients: a potential mediator of wasting?J Ockenga, A Widjaja, M Holtmannspötter, et al.
Annals of Nutrition & Metabolism|September 6, 2000
Tumor necrosis factor, interleukin-6,and epinephrine are associated with hypermetabolism in AIDS patients with acute opportunistic infectionsU Süttmann, M Holtmannspötter, J Ockenga, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 28, 2005
Nutritional assessment and management in hospitalised patients: implication for DRG-based reimbursement and health care qualityJ Ockenga, M Freudenreich, R Zakonsky, et al.
Gastroenterology|March 26, 1999
Octreotide for therapy of chylous ascites in yellow nail syndromeA Widjaja, K F Gratz, J Ockenga, et al.
Pageof 7